Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Bigham Michael was granted 156,250 shares and sold $68,750 worth of shares (31,250 units at $2.20), increasing direct ownership by 10% to 1,334,702 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.